Skip to navigation Skip to main content

Your search for dabigatran returned 116 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for dabigatran returned 116 results

Sort Results:

Relevant Recent
Drug News

Dabigatran vs.Warfarin: New Findings Conflict with FDA Analysis

Publish Date
Dabigatran is associated with higher risks of major bleeding and gastrointestinal bleeding compared with warfarin, but patients taking dabigatran also have a reduced risk of intracranial bleeding compared with those taking warfarin, according to new research.
American College of Cardiology 2013

Similar Bleeding and Thrombotic Complication Rates Between Dabigatran and Rivaroxaban

Publish Date
At ACC.13, the American College of Cardiology's 62nd Annual Scientific Session, Anil Rajendra, MD, from the Medical University of South Carolina, in Charleston, SC, presented data showing similar bleeding and thrombotic complication rates at the time of atrial fibrillation ablation (AFA) in patients anticoagulated with dabigatran and rivaroxaban. Dr. Rajendra and colleagues determined that rivaroxaban has an acceptable safety profile for AFA.
Drugs in the Pipeline

Antidote for Pradaxa Demonstrates Efficacy in Study

Publish Date
Boehringer Ingelheim announced results demonstrating that its investigational fully humanized antibody fragment (Fab) rapidly reversed the anticoagulation effect of dabigatran in healthy male volunteers.
American College of Cardiology 2013

Dabigatran Safe and Effective Post-Atrial Fibrillation Ablation

Publish Date
At ACC.13, the American College of Cardiology's 62nd Annual Scientific Session, leading cardiologists presented that the use of dabigatran following ablation for atrial fibrillation resulted in no major post-procedural complications.